Browse Related Topics For:

Generic Drugs The United States Food and Drug Administration

215
Pharmaceutical Industry
131
Prescription Drugs
122
Pharmaceutical Patents
112
ANDA
108
Patents
98
Hatch-Waxman
94
Patent Infringement
81
Patent Litigation
46
Biosimilars
38
Patent-in-Suit
29
SCOTUS
27
Preemption
25
FDCA
24
Intellectual Property Protection
24
Labeling
23
BPCIA
21
Medical Devices
19
Sandoz
18
FTC
16
Apotex
16
Appeals
16
Drug Pricing
16
Manufacturers
16
Mylan Pharmaceuticals
15
Amgen
15
Biologics
15
Failure To Warn
14
FDA Approval
14
Popular
13
Teva Pharmaceuticals
12
Affordable Care Act
12
Antitrust Litigation
12
Commercial Marketing
12
Healthcare
12
Reverse Payment Settlement Agreements
11
PLIVA v Mensing
11
Sandoz v Amgen
10
Patent Dance
10
Trump Administration
10
Warning Labels
9
FTC v Actavis
8
Actavis Inc.
8
HHS
8
Medicare
8
Orange Book
8
Orphan Drugs
8
Preliminary Injunctions
8
Prior Art
8
Product Exclusivity
7
Class Action
7
Competition
7
Corporate Counsel
7
Draft Guidance
7
Notice Requirements
7
Patent Applications
6
Declaratory Judgments
6
GDUFA
6
Life Sciences
6
Medicaid
6
Personal Jurisdiction
6
Product Hopping
6
Product Labels
6
REMS
6
Sherman Act
6
Summary Judgment
6
USPTO
6
Watson Pharmaceuticals
5
aBLA
5
Antitrust Violations
5
Biologics Price Competition and Innovation Act of 2009
5
GlaxoSmithKline
5
Health Care Providers
5
Monopolization
5
Mutual Pharmaceuticals v Bartlett
5
Otsuka Pharmaceutical
5
Patent Invalidity
5
Proposed Regulation
5
Safe Harbors
5
User Fees
4
Amarin
4
Anti-Competitive
4
CMS
4
Design Defects
4
DOJ
4
Drug Safety
4
Endo Pharmaceuticals
4
Exclusivity
4
Inter Partes Review (IPR) Proceeding
4
Multidistrict Litigation
4
No-AG Agreement
4
Obviousness
4
Off-Label Promotion
4
OIG
4
On-Sale Bar
4
Pay-For-Delay
4
Proposed Legislation
4
Standing
4
Supply Chain
3
21st Century Cures Initiative
3
AbbVie
3
Allergan Inc
3
America Invents Act
3
Antitrust Provisions
3
AstraZeneca
3
Bayer
3
Biotechnology
3
Brand
3
Citizen Petitions
3
Classen Immunotherapies
3
Comment Period
3
Congressional Investigations & Hearings
3
Drug Compounding
3
Elan Pharmaceuticals
3
Eli Lilly
3
FDA Reauthorization Act
3
FDARA
3
FDASIA
3
Federal Rule 12(b)(6)
3
Foreign Manufacturers
3
Healthcare Reform
3
Hospira
3
Hospitals
3
Innovator Liability
3
Jurisdiction
3
Learned Intermediary
3
Legislative Agendas
3
Licensing Rules
3
Medicare Part B
3
Mensing
3
Merck
3
New Legislation
3
NIH
3
Off-Label Use
3
PDUFA
3
Pharmacies
3
Pleading Standards
3
Professional Conferences
3
Public Health Service Act
3
Rule-of-Reason Analysis
3
Rulemaking Process
3
Spectrum
3
Takeda Pharmaceuticals
3
Telehealth
3
Trademarks
2
Allergan v Sandoz
2
Antitrust Injuries
2
Aurobindo Pharmaceuticals
2
Canada
2
Cancer
2
Causation
2
CDC
2
Center for Drug Evaluation and Research (CDER)
2
Cephalon
2
Chevron Deference
2
China
2
CHIP
2
Class Certification
2
Clinical Trials
2
Co-Op
2
Congressional Committees
2
Contraceptive Coverage Mandate
2
DaimlerAG
2
DaimlerChrysler v Bauman
2
Dismissals
2
Durable Medical Equipment
2
Duty to Deal
2
E-Cigarettes
2
Enforcement Actions
2
EU
2
False Advertising
2
False Claims Act (FCA)
2
FDA Commissioner
2
Federal Budget
2
First Amendment
2
Food Safety
2
Free Speech
2
General Jurisdiction
2
Health Information Technologies
2
Induced Infringement
2
Injunctive Relief
2
Innovation
2
Inspections
2
INTERPOL
2
Medicare Part D
2
Medicare Prescription Drug Improvement and Modernization Act (MMA)
2
MedPAC
2
Medtronic
2
Mental Health
2
Motion to Dismiss
2
Motion To Stay
2
Novartis
2
Opioid
2
Par Pharmaceutical
2
Patent Trial and Appeal Board
2
Pediatrics
2
Pending Legislation
2
Permanent Injunctions
2
PHRMA
2
Product Defects
2
Public Meetings
2
Putative Class Actions
2
Rebates
2
Regulatory Standards
2
Reversal
2
Roxane Laboratories
2
SEC
2
Section 340B
2
SNDAs
2
Standard of Review
2
Substance Abuse
2
Suppliers
2
Telemedicine
2
Transfer of Venue
2
TRO
2
Twombly/Iqbal Pleading Standard
2
Unfair Competition
2
Websites
2
Wyeth
1
35 U.S.C. § 271(e)(1)
1
3D Printing
1
510(k) RTA
1
Abbott Laboratories
1
ACOs
1
Actos
1
Advance Notice
1
Alternative Payment Models (APM)
1
Amended Complaints
1
Amended Regulation
1
Anti-Monopoly
1
Antibiotics
1
Antitrust Conspiracies
1
App Developers
1
Article III
1
Attorney Generals
1
Australia
1
Automatic Enrollment
1
Barack Obama
1
Best Practices
1
Bifurcation
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Books
1
BPCI
1
Bristol-Myers Squibb
1
BsUFA
1
Burden of Proof
1
CA Supreme Court
1
Cadillac Tax
1
CAFC
1
Cartwright Act
1
Carve Out Provisions
1
Cipro
1
Civil Monetary Penalty
1
Claim Construction
1
Clearance
1
CLIA
1
Collateral Estoppel
1
Community Trademark
1
Compliance
1
Confidential Information
1
Conflicting Proposals
1
Congressional Budget Office
1
Copyright
1
Copyright Infringement
1
Corrective Actions
1
Cost-Sharing
1
Counterclaims
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Daiichi Sankyo
1
Defect
1
Delaware General Corporation Law
1
Department of Veterans Affairs
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Tests
1
Dietary Supplements
1
Direct Purchasers
1
Disclosure
1
Disclosure Requirements
1
Discovery Rule
1
Disgorgement
1
Doctrine of Equivalents
1
DOHA
1
DOL
1
DQSA
1
Drug & Alcohol Abuse
1
Drug Design
1
Duty to Warn
1
EAR
1
EHR
1
Elder Issues
1
Email
1
Employer Mandates
1
Enforcement
1
Evidence Suppression
1
Exceptional Case
1
Excessive Pricing
1
Executive Orders
1
Expert Testimony
1
Expiration Date
1
Exports
1
False Evidence
1
FCPA
1
FD&C Act
1
Federal Question Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Fee-for-Service
1
Filing Fees
1
Final Rules
1
First Sale Doctrine
1
Food and Drug Administration Amendments Act (FDAAA)
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Foreseeability
1
Forest Laboratories
1
Forum Shopping
1
Fraudulent Concealment
1
FTEs
1
GAO
1
Generic
1
Genzyme
1
Gilead Sciences
1
Goodyear
1
Government Investigations
1
GPOs
1
Grable Factors
1
Health Insurance
1
Health Safety
1
Highmark v. Allcare
1
HIPAA
1
Hoffman LaRoche
1
Home Health Care
1
Hurricane Maria
1
ICD-10
1
Implied Preemption
1
Imports
1
Information Reports
1
Informed Consent
1
Intellectual Property Litigation
1
Intermediaries
1
International Arbitration
1
International Harmonization
1
International Treaties
1
Inventions
1
Investigational New Drug Application (IND)
1
Investors
1
IPAB
1
IRF Claim Processing
1
Issue Preclusion
1
Janssen Pharmaceuticals
1
Johnson & Johnson
1
Justiciable Controversy
1
Kickbacks
1
Lanham Act
1
Leave to Amend
1
Legislative Riders
1
License Agreements
1
Licenses
1
Long Term Care Facilities
1
Manufacturing Defects
1
Manufacturing Facilities
1
Market Manipulation
1
Marketing
1
Medical Device User Fee Program (MDUFA IV)
1
Medical Foods
1
Medical Research
1
Medicare Modernization Act
1
Method Claims
1
Misrepresentation
1
Mootness
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Compel
1
National Evaluation System for Health Technology (NEST)
1
Native American Issues
1
Natural Disasters
1
Negligence
1
New Guidance
1
New Regulations
1
New Trial
1
Nexus
1
Nike
1
NJ Supreme Court
1
Nominations
1
Non-Grandfathered Health Plans
1
Notice of Intent
1
Notifications
1
Numerosity
1
Nursing Homes
1
Nutritional Supplements
1
OCR
1
Octane Fitness v. ICON
1
Office of Regulatory Affairs (ORA)
1
Open Enrollment
1
OPPS
1
Out-of-State Companies
1
Out-of-State Judgments
1
Over-the-Counter Sales
1
OxyContin
1
PACE
1
Patent Term Extensions
1
Patent-Misuse
1
Pfizer
1
Pharmacist
1
PHSA
1
Physician Fee Schedule
1
Physician Medicare Reimbursements
1
Post-Grant Review
1
Post-Market Approval
1
Power Outages
1
Prescription Drug Coverage
1
Presidential Elections
1
Price Transparency
1
Price-Fixing
1
Private Right of Action
1
Prometheus
1
Proposed Amendments
1
Proposed Rules
1
Public Comment
1
Public Hearing
1
Public Performance Rights
1
Public Use
1
Qui Tam
1
RanBaxy
1
Reauthorization
1
Recordkeeping Requirements
1
Registration Requirement
1
Regulatory Oversight
1
Renewal Fees
1
Repeal
1
Res Ipsa Loquitur
1
Research and Development
1
Restraining Orders
1
Reverse Payments
1
RICO
1
Risk Assessment
1
Risk Management
1
Risk Mitigation
1
Rule 23
1
Rural Areas
1
Rural Health Care Program
1
SAMHSA
1
Sanofi
1
Senate Judiciary Committee
1
Settlement
1
Settlement Agreements
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
Skilled Nursing Facility
1
SmithKline Beecham
1
Social Security
1
Specific Jurisdiction
1
Spoliation
1
State Health Insurance Exchanges
1
State Law Tort Claims
1
Subject Matter Jurisdiction
1
Tax Credits
1
Tobacco Regulations
1
Trade Policy
1
Trade Secrets
1
Trademark Registration
1
Trademark Searches
1
Transvaginal Mesh
1
Two-Midnight Rule
1
U.S. Treasury
1
Uniform Commercial Code (UCC)
1
Universal Health Services Inc v United States ex rel Escobar
1
Vaccinations
1
Venue
1
Veterans
1
Veterinary Products
1
Warner Chilcott
1
Webinars
1
Whistleblowers
1
WIPO
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
WTO
1
Young Lawyers
1
Zofran